Peerapornratana S, Manrique-Caballero CL, Gómez H, Kellum JA. Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment. Kidney Int. 2019;96(5):1083–99.

Article  PubMed  PubMed Central  Google Scholar 

Gumbert SD, Kork F, Jackson ML, Vanga N, Ghebremichael SJ, Wang CY, et al. Perioperative acute kidney injury. Anesthesiology. 2020;132(1):180–204.

Article  PubMed  Google Scholar 

Medić B, Stojanović M, Rovčanin B, Kekić D, Škodrić SR, Jovanović GB, et al. Pioglitazone attenuates kidney injury in an experimental model of gentamicin-induced nephrotoxicity in rats. Sci Rep. 2019;9(7):13689.

Article  PubMed  PubMed Central  Google Scholar 

Jha JC, Banal C, Chow BS, Cooper ME, Jandeleit-Dahm K. Diabetes and kidney disease: role of oxidative stress. Antioxid Redox Signal. 2016;25(12):657–84.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zou G, Zhou Z, Xi X, Huang R, Hu H. Pioglitazone ameliorates renal ischemia-reperfusion injury via inhibition of NF-κB activation and inflammation in rats. Front Physiol. 2021;12: 707344.

Article  PubMed  PubMed Central  Google Scholar 

Kaltenmeier C, Wang R, Popp B, Geller D, Tohme S, Yazdani HO. Role of immuno-inflammatory signals in liver ischemia-reperfusion injury. Cells. 2022;11(14):2222.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pefanis A, Ierino FL, Murphy JM, Cowan PJ. Regulated necrosis in kidney ischemia-reperfusion injury. Kidney Int. 2019;96(2):291–301.

Article  PubMed  Google Scholar 

Su L, Zhang J, Gomez H, Kellum JA, Peng Z. Mitochondria ROS and mitophagy in acute kidney injury. Autophagy. 2023;19(2):401–14.

Article  CAS  PubMed  Google Scholar 

Zhang BH, Liu H, Yuan Y, Weng XD, Du Y, Chen H, et al. Knockdown of TRIM8 protects HK-2 cells against hypoxia/reoxygenation-induced injury by inhibiting oxidative stress-mediated apoptosis and pyroptosis via PI3K/Akt signal pathway. Drug Des Dev Ther. 2021;15:4973–83.

Article  CAS  Google Scholar 

Liu W, Gan Y, Ding Y, Zhang L, Jiao X, Liu L, et al. Autophagy promotes GSDME-mediated pyroptosis via intrinsic and extrinsic apoptotic pathways in cobalt chloride-induced hypoxia reoxygenation-acute kidney injury. Ecotoxicol Environ Saf. 2022;242:113881.

Article  CAS  PubMed  Google Scholar 

Devchand PR, Liu T, Altman RB, FitzGerald GA, Schadt EE. The pioglitazone trek via human PPAR gamma: from discovery to a medicine at the FDA and beyond. Front Pharmacol. 2018;9:1093.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Richter B, Bandeira-Echtler E, Bergerhoff K, Clar C, Ebrahim SH. Pioglitazone for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2006;2006(4):Cd006060.

PubMed  PubMed Central  Google Scholar 

Nesti L, Tricò D, Mengozzi A, Natali A. Rethinking pioglitazone as a cardioprotective agent: a new perspective on an overlooked drug. Cardiovasc Diabetol. 2021;20(1):109.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yi HJ, Lee JE, Lee DH, Kim YI, Cho CB, Kim IS, et al. The role of NLRP3 in traumatic brain injury and its regulation by pioglitazone. J Neurosurg. 2019. https://doi.org/10.3171/2019.6.JNS1954.

Article  PubMed  Google Scholar 

Zhang H, Huang C, Zhang D, Zhu Y. Pioglitazone protects against hypoxia-induced cardiomyocyte apoptosis through inhibiting NLRP3/caspase-1 pathway in vivo and in vitro. Int Heart J. 2022;63(5):893–903.

Article  CAS  PubMed  Google Scholar 

Chen W, Xi X, Zhang S, Zou C, Kuang R, Ye Z, et al. Pioglitazone Protects against renal ischemia-reperfusion injury via the AMP-activated protein kinase-regulated autophagy pathway. Front Pharmacol. 2018;9:851.

Article  PubMed  PubMed Central  Google Scholar 

Zou C, Zhou Z, Tu Y, Wang W, Chen T, Hu H. Pioglitazone attenuates reoxygenation injury in renal tubular NRK-52E cells exposed to high glucose via inhibiting oxidative stress and endoplasmic reticulum stress. Front Pharmacol. 2019;10:1607.

Article  CAS  PubMed  Google Scholar 

Acar M, Sayhan Kaplan H, Erdem AF, Tomak Y, Turan G, Özdin M. Effects of dexmedetomidine on new oxidative stress markers on renal ischaemia-reperfusion injury in rats: thiol/disulphide homeostasis and the ischaemia-modified albumin. Arch Physiol Biochem. 2022;128(4):1115–20.

Article  CAS  PubMed  Google Scholar 

Choi HY, Moon SJ, Ratliff BB, Ahn SH, Jung A, Lee M, et al. Microparticles from kidney-derived mesenchymal stem cells act as carriers of proangiogenic signals and contribute to recovery from acute kidney injury. PLoS ONE. 2014;9(2): e87853.

Article  PubMed  PubMed Central  Google Scholar 

Zheng Z, Xu K, Li C, Qi C, Fang Y, Zhu N, et al. NLRP3 associated with chronic kidney disease progression after ischemia/reperfusion-induced acute kidney injury. Cell death discovery. 2021;7(1):324.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hu H, Zou C, Xi X, Shi Z, Wang G, Huang X. Protective effects of pioglitazone on renal ischemia-reperfusion injury in mice. J Surg Res. 2012;178(1):460–5.

Article  CAS  PubMed  Google Scholar 

Wolf P, Schoeniger A, Edlich F. Pro-apoptotic complexes of BAX and BAK on the outer mitochondrial membrane. Biochim Biophys Acta. 2022;1869(10): 119317.

Article  CAS  Google Scholar 

Eskandari E, Eaves CJ. Paradoxical roles of caspase-3 in regulating cell survival, proliferation, and tumorigenesis. J Cell Biol. 2022;221(6):e202201159.

Article  PubMed  PubMed Central  Google Scholar 

Minutoli L, Puzzolo D, Rinaldi M, Irrera N, Marini H, Arcoraci V, et al. ROS-mediated NLRP3 inflammasome activation in brain, heart, kidney, and testis ischemia/reperfusion injury. Oxid Med Cell Longev. 2016;2016:2183026.

Article  PubMed  PubMed Central  Google Scholar 

Sharma BR, Kanneganti TD. NLRP3 inflammasome in cancer and metabolic diseases. Nat Immunol. 2021;22(5):550–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tapia-Abellán A, Angosto-Bazarra D, Martínez-Banaclocha H, de Torre-Minguela C, Cerón-Carrasco JP, Pérez-Sánchez H, et al. MCC950 closes the active conformation of NLRP3 to an inactive state. Nat Chem Biol. 2019;15(6):560–4.

Article  PubMed  PubMed Central  Google Scholar 

Sharif H, Wang L, Wang WL, Magupalli VG, Andreeva L, Qiao Q, et al. Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome. Nature. 2019;570(7761):338–43.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao M, Wang Y, Li L, Liu S, Wang C, Yuan Y, et al. Mitochondrial ROS promote mitochondrial dysfunction and inflammation in ischemic acute kidney injury by disrupting TFAM-mediated mtDNA maintenance. Theranostics. 2021;11(4):1845–63.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tang C, Hu Y, Gao J, Jiang J, Shi S, Wang J, et al. Dexmedetomidine pretreatment attenuates myocardial ischemia reperfusion induced acute kidney injury and endoplasmic reticulum stress in human and rat. Life Sci. 2020;257: 118004.

Article  CAS  PubMed  Google Scholar 

Yang CC, Sung PH, Chiang JY, Chai HT, Chen CH, Chu YC, et al. Combined tacrolimus and melatonin effectively protected kidney against acute ischemia-reperfusion injury. FASEB J. 2021;35(6): e21661.

Article  CAS  PubMed  Google Scholar 

Liu X, Zhang P, Song X, Cui H, Shen W. PPARγ mediates protective effect against hepatic ischemia/reperfusion injury via NF-κB pathway. J Invest Surg. 2022;35(8):1648–59.

Article  PubMed  Google Scholar 

DeFronzo RA, Inzucchi S, Abdul-Ghani M, Nissen SE. Pioglitazone: the forgotten, cost-effective cardioprotective drug for type 2 diabetes. Diab Vasc Dis Res. 2019;16(2):133–43.

Article  CAS  PubMed  Google Scholar 

Betz B, Schneider R, Kress T, Schick MA, Wanner C, Sauvant C. Rosiglitazone affects nitric oxide synthases and improves renal outcome in a rat model of severe ischemia/reperfusion injury. PPAR Res. 2012;2012: 219319.

Article  PubMed  PubMed Central  Google Scholar 

Reel B, Guzeloglu M, Bagriyanik A, Atmaca S, Aykut K, Albayrak G, et al. The effects of PPAR-γ agonist pioglitazone on renal ischemia/reperfusion injury in rats. J Surg Res. 2013;182(1):176–84.

Article  CAS  PubMed  Google Scholar 

Ali SM, Khalifa H, Mostafa DK, El Sharkawy A. Suppression of connective tissue growth factor mediates the renoprotective effect of sitagliptin rather than pioglitazone in type 2 diabetes mellitus. Life Sci. 2016;153:180–7.

Article  CAS  PubMed  Google Scholar 

Xue Y, Enosi Tuipulotu D, Tan WH, Kay C, Man SM. Emerging activators and regulators of inflammasomes and pyroptosis. Trends Immunol. 2019;40(11):1035–52.